BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND FH, HLRCC, 2271, ENSG00000091483, MCUL1, MCL, LRCC, P07954 AND Prognosis
21 results:

  • 1. BCL-X
    Jenkins LJ; Luk IY; Chionh F; Tan T; Needham K; Ayton J; Reehorst CM; Vukelic N; Sieber OM; Mouradov D; Gibbs P; Williams DS; Tebbutt NC; Desai J; Hollande F; Dhillon AS; Lee EF; Merino D; Fairlie WD; Mariadason JM
    Cell Death Dis; 2024 Mar; 15(3):183. PubMed ID: 38429301
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Engulfment and Cell Motility 1 (ELMO1) Regulates Tumor Cell Behavior and Predicts prognosis in colorectal cancer.
    Park YL; Cho SB; Park SY; Oh HH; Myung E; Im CM; Son S; Kim S; Cho SY; Chung MW; Hong JY; Kim KH; Myung DS; Lee WS; Park D; Joo YE
    Anticancer Res; 2022 Nov; 42(11):5343-5355. PubMed ID: 36288887
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Skp2 stabilizes mcl-1 and confers radioresistance in colorectal cancer.
    Yu X; Zhou L; Liu W; Liu L; Gao F; Li W; Liu H
    Cell Death Dis; 2022 Mar; 13(3):249. PubMed ID: 35301297
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Anticancer Activity of 2-
    Chae HJ; Kim GJ; Deshar B; Kim HJ; Shin MJ; Kwon H; Youn UJ; Nam JW; Kim SH; Choi H; Suh SS
    Molecules; 2021 Jun; 26(13):. PubMed ID: 34203232
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A novel kinase inhibitor, LZT-106, downregulates mcl-1 and sensitizes colorectal cancer cells to BH3 mimetic ABT-199 by targeting CDK9 and GSK-3β signaling.
    Yu Z; Du J; Zhao Y; Gao Y; Li Y; Zhao K; Lu N
    Cancer Lett; 2021 Feb; 498():31-41. PubMed ID: 33129955
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer.
    Roberti MP; Yonekura S; Duong CPM; Picard M; Ferrere G; Tidjani Alou M; Rauber C; Iebba V; Lehmann CHK; Amon L; Dudziak D; Derosa L; Routy B; Flament C; Richard C; Daillère R; Fluckiger A; Van Seuningen I; Chamaillard M; Vincent A; Kourula S; Opolon P; Ly P; Pizzato E; Becharef S; Paillet J; Klein C; Marliot F; Pietrantonio F; Benoist S; Scoazec JY; Dartigues P; Hollebecque A; Malka D; Pagès F; Galon J; Gomperts Boneca I; Lepage P; Ryffel B; Raoult D; Eggermont A; Vanden Berghe T; Ghiringhelli F; Vandenabeele P; Kroemer G; Zitvogel L
    Nat Med; 2020 Jun; 26(6):919-931. PubMed ID: 32451498
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Obatoclax, a Pan-BCL-2 Inhibitor, Downregulates Survivin to Induce Apoptosis in Human colorectal Carcinoma Cells Via Suppressing WNT/β-catenin Signaling.
    Or CR; Huang CW; Chang CC; Lai YC; Chen YJ; Chang CC
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32150830
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Association of family history of tumors with clinicopathological characteristics and prognosis of colorectal cancer.
    Shan T; Chen S; Chen X; Lin W; Li W; Ma J; Wu T; Cui X; Li W; Kang Y; Yang W
    Eur J Cancer Prev; 2019 Jul; 28(4):258-267. PubMed ID: 31145132
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Impact of Family History on prognosis of Patients with Sporadic colorectal cancer.
    Lee SY; Kim DW; Kang SI; Ihn MH; Oh HK; Kang SB; Kim CH; Kim HR; Kim YJ; Ju JK
    Ann Surg Oncol; 2019 Apr; 26(4):1118-1126. PubMed ID: 30684157
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Magnolin promotes autophagy and cell cycle arrest via blocking LIF/Stat3/mcl-1 axis in human colorectal cancers.
    Yu H; Yin S; Zhou S; Shao Y; Sun J; Pang X; Han L; Zhang Y; Gao X; Jin C; Qiu Y; Wang T
    Cell Death Dis; 2018 Jun; 9(6):702. PubMed ID: 29899555
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. YAP transcriptionally regulates COX-2 expression and GCCSysm-4 (G-4), a dual YAP/COX-2 inhibitor, overcomes drug resistance in colorectal cancer.
    Li W; Cao Y; Xu J; Wang Y; Li W; Wang Q; Hu Z; Hao Y; Hu L; Sun Y; Xu G; Ao G
    J Exp Clin Cancer Res; 2017 Oct; 36(1):144. PubMed ID: 29037225
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Differences of protein expression profiles, KRAS and BRAF mutation, and prognosis in right-sided colon, left-sided colon and rectal cancer.
    Gao XH; Yu GY; Gong HF; Liu LJ; Xu Y; Hao LQ; Liu P; Liu ZH; Bai CG; Zhang W
    Sci Rep; 2017 Aug; 7(1):7882. PubMed ID: 28801584
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Mutant BRAF Upregulates mcl-1 to Confer Apoptosis Resistance that Is Reversed by mcl-1 Antagonism and Cobimetinib in colorectal cancer.
    Kawakami H; Huang S; Pal K; Dutta SK; Mukhopadhyay D; Sinicrope FA
    Mol Cancer Ther; 2016 Dec; 15(12):3015-3027. PubMed ID: 27765849
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Genetic variations in genes of metabolic enzymes predict postoperational prognosis of patients with colorectal cancer.
    Dong G; He X; Chen Y; Cao H; Wang J; Liu X; Wang S; Wan S; Xing J
    Mol Cancer; 2015 Sep; 14():171. PubMed ID: 26377099
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Pan-Bcl-2 inhibitor obatoclax delays cell cycle progression and blocks migration of colorectal cancer cells.
    Koehler BC; Scherr AL; Lorenz S; Elssner C; Kautz N; Welte S; Jaeger D; Urbanik T; Schulze-Bergkamen H
    PLoS One; 2014; 9(9):e106571. PubMed ID: 25192188
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Influence of family history on survival in patients with colon and rectal cancer.
    Lee SD; Kim BC; Han KS; Hong CW; Sohn DK; Park JW; Park SC; Kim SY; Baek JY; Chang HJ; Kim DY; Oh JH
    J Dig Dis; 2014 Mar; 15(3):108-15. PubMed ID: 24304621
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Reported prevalence of family history of colorectal cancer in the city of Gijon (Spain)].
    Ferrero Fernández IE; Echevarría Broz C; Miguel González I; Horta Valvidares M; García González JV
    Semergen; 2012; 38(8):498-504. PubMed ID: 23146702
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Lymphoma of the colon.
    Romaguera J; Hagemeister FB
    Curr Opin Gastroenterol; 2005 Jan; 21(1):80-4. PubMed ID: 15687889
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Carbohydrate expression profile of colorectal cancer cells is relevant to metastatic pattern and prognosis.
    Konno A; Hoshino Y; Terashima S; Motoki R; Kawaguchi T
    Clin Exp Metastasis; 2002; 19(1):61-70. PubMed ID: 11918084
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Outcome after ovarian/adnexal metastectomy in metastatic colorectal carcinoma.
    Rayson D; Bouttell E; Whiston F; Stitt L
    J Surg Oncol; 2000 Nov; 75(3):186-92. PubMed ID: 11088050
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.